[Retracted] Identification of the Novel Methylated Genes’ Signature to Predict Prognosis in INRG High-Risk Neuroblastomas

Table 2

Univariable and multivariable Cox regression analyses of the association between the eight methylated genes’ signature and the survival of neuroblastoma patients in the total group (n = 130).

Variables		HR	95% CI of HR
			Lower	Upper
Univariable analysis
Gender	Male vs. female	1.17	0.73	1.87	0.52
Age	>18 months vs. ≤18	0.97	0.90	1.06	0.51
MYCN status	Amplified vs. non	1.24	0.77	1.98	0.38
Methylated genes’ signature	High risk vs. low risk	2.02	1.65	2.47	≤0.001
Multivariable analysis
Gender	Male vs. female	0.89	0.55	1.44	0.64
Age	>18 months vs. ≤18	1.01	0.93	1.11	0.79
MYCN status	Amplified vs. non	0.77	0.46	1.30	0.33
Methylated genes’ signature	High risk vs. low risk	2.13	1.70	2.66	≤0.001